Andrea Galbiati is giving a presentation about Philochem’s FAP-targeted radioligand therapeutics on October 20 (session 604), entitled “Development of Multivalent OncoFAP Derivatives for the Tumor-Targeted Delivery of Theranostic Radionuclides”.

Dr. Sebastian Oehler will present Philochem’s work on “DNA-Encoded Chemical Library-derived high-affinity Prostatic Acid Phosphatase ligands for the delivery of radionuclides to prostate cancer” on October 22 (session 1604).

Dr. Margarita Kirienko will present the Phase I clinical trial of Philochem’s diagnostic radiopharmaceutical ⁶⁸Ga-OncoFAP on October 22^nd (session 1606) in a talk entitled “Safety, pharmacokinetics, and preliminary imaging findings of ⁶⁸Ga-OncoFAP based on a prospective multicentre Phase I clinical trial in patients with breast, oesophageal, pancreatic and colorectal cancer”.

Prof. Alessia Artesani will present a poster entitled “Dosimetry of ⁶⁸Ga-OncoFAP based on a prospective Phase I clinical trial”.

Follow the link for more details.